901 filings
Page 4 of 46
SC 13D/A
yhyl64u qt
10 Jan 23
Armata Pharmaceuticals / Innoviva ownership change
5:12pm
8-K
qkkmnjq3y9r80j580n7
10 Jan 23
Armata Pharmaceuticals Announces Closing of $30 Million Secured Convertible Credit Agreement with Innoviva Strategic Opportunities LLC
9:34am
8-K
kdi qxcyk3l9fr
19 Dec 22
Departure of Directors or Certain Officers
3:24pm
8-K
k08417rpk7je70ke
18 Nov 22
Submission of Matters to a Vote of Security Holders
12:13pm
8-K
7sacxcl3cag8w1y ndz
9 Nov 22
Armata Pharmaceuticals Announces Third Quarter 2022 Results and Provides Corporate Update
4:11pm
8-K
88b3 lvn7uo
20 Sep 22
Results of Operations and Financial Condition
5:23pm
8-K
yqqtc4y rt
11 Aug 22
Armata Pharmaceuticals Announces Second Quarter 2022 Results and Provides Corporate Update
4:10pm
EFFECT
dncvudn5c7412yh5k
1 Jun 22
Notice of effectiveness
12:15am
424B3
fqu4 srci
31 May 22
Prospectus supplement
6:49pm
CORRESP
9pyudxx
26 May 22
Correspondence with SEC
12:00am
UPLOAD
2a4swrgq5 0ck
19 May 22
Letter from SEC
12:00am
4
l8h3l
15 Apr 22
Armata Pharmaceuticals / Todd C. Peterson ownership change
3:56pm
4
skx41jbo
15 Apr 22
Armata Pharmaceuticals / Todd Patrick ownership change
3:55pm
4
i3hxa43r0x qmlqkq
15 Apr 22
Armata Pharmaceuticals / Sarah J. Schlesinger ownership change
3:54pm